Sickle Cell Disease Clinical Trials
Sickle Cell Disease clinical trials are research studies evaluating new treatments, therapies, and approaches for sickle Cell Disease. Corterve aggregates actively recruiting Sickle Cell Disease studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility criteria. Participation is always voluntary. This page provides general information and is not medical advice; discuss any trial with your healthcare provider before taking part.
Recruiting Sickle Cell Disease studies
- Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive CrisisNCT06699849PHASE2CSL BehringSickle Cell Disease Vaso-occlusive CrisisOakland, California
- Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell DiseaseNCT05904093PHASE1National Heart, Lung, and Blood Institute (NHLBI)Sickle Cell DisordersBethesda, Maryland
- Peer Support for Adolescents and Emerging Adults With Sickle Cell PainNCT06374238NAUniversity of PittsburghPainMobile, Alabama
- A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)NCT07187973PHASE1Disc Medicine, IncSickle Cell DiseaseBirmingham, Alabama
- Collection of Human Biospecimens for Basic and Clinical Research Into Globin VariantsNCT03937817National Institute of Allergy and Infectious Diseases (NIAID)Alpha and Beta ThalassemiaBethesda, Maryland
- Exercise in Child HealthNCT05359991NAUniversity of California, IrvineCystic FibrosisIrvine, California
- A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell DiseaseNCT04055818PHASE1EpiDestiny, Inc.Sickle Cell DiseaseChicago, Illinois
- Blood Sampling for Research Related to Sickle Cell DiseaseNCT00542230National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sickle Cell TraitBethesda, Maryland
- Determination of Red Cell Survival in Sickle Cell Disease and Other Hemoglobinopathies Using Biotin LabelingNCT06313398EARLY_PHASE1National Heart, Lung, and Blood Institute (NHLBI)Sickle Cell DiseaseBethesda, Maryland
- A Study to Investigate the Effect of Mitapivat on Transfusion Burden in Subjects With Sickle Cell Disease (SCD)NCT07656415PHASE3Agios Pharmaceuticals, Inc.Sickle Cell DiseaseIndianapolis, Indiana
- A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)NCT06439082PHASE3Novartis PharmaceuticalsSickle Cell DiseaseBirmingham, Alabama
- Dietary Intake and Dietary Behaviors in Adults With Sickle Cell DiseaseNCT05170412National Institutes of Health Clinical Center (CC)Sickle Cell DiseaseBethesda, Maryland
Sickle Cell Disease trials by state
Sickle Cell Disease trials by metro
Frequently asked questions
- How do I find recruiting Sickle Cell Disease clinical trials?
- Browse the actively recruiting Sickle Cell Disease studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Sickle Cell Disease clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Sickle Cell Disease clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.